AR and prostate neoplasm: To determine the effect of ADT on tumor-cell proliferation, 2 human prostate tumor-cell lines, LNCaP (AR+, HLA-A2) and PC-3 (AR−, HLA-A24), were treated in vitro with vehicle (DMSO) or 10 μM enzalutamide or abiraterone.